[{"NetIncomeLoss_3_Q3_USD":-53079000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_3_Q3_USD":-49000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_1_Q3_USD":-277000.0,"PreferredStockSharesOutstanding_0_Q3_shares":0.0,"RepaymentsOfLongTermDebt_3_Q3_USD":210760000.0,"CommitmentsAndContingencies_0_Q3_USD":null,"AccruedLiabilitiesCurrent_0_Q3_USD":58497000.0,"InterestPaidNet_3_Q3_USD":16892000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q3_USD":35000.0,"NetCashProvidedByUsedInInvestingActivities_3_Q3_USD":336655000.0,"StockIssuedDuringPeriodValueNewIssues_1_Q3_USD":14096000.0,"PaymentsToAcquireInvestments_3_Q3_USD":53197000.0,"AccruedLiabilitiesCurrentAndNoncurrent_0_Q3_USD":58497000.0,"AssetsCurrent_0_Q3_USD":121938000.0,"Liabilities_0_Q3_USD":91289000.0,"IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_3_Q3_shares":0.0,"LongTermDebtCurrent_0_Q3_USD":8691000.0,"CostOfGoodsAndServicesSold_3_Q3_USD":1929000.0,"CostOfGoodsAndServicesSold_1_Q3_USD":633000.0,"TreasuryStockShares_0_Q3_shares":793000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_3_Q3_shares":11859000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q3_shares":11773000.0,"AvailableForSaleSecurities_0_Q3_USD":59195000.0,"TreasuryStockValue_0_Q3_USD":4843000.0,"RoyaltyIncomeNonoperating_3_Q3_USD":359000.0,"RoyaltyIncomeNonoperating_1_Q3_USD":92000.0,"CommonStockSharesIssued_0_Q3_shares":117231000.0,"Assets_0_Q3_USD":178928000.0,"ShareBasedCompensation_3_Q3_USD":10594000.0,"IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_1_Q3_shares":51000.0,"PreferredStockParOrStatedValuePerShare_0_Q3_USD":0.01,"ProceedsFromSaleMaturityAndCollectionsOfInvestments_3_Q3_USD":229500000.0,"OtherAssetsNoncurrent_0_Q3_USD":1341000.0,"ResearchAndDevelopmentExpense_1_Q3_USD":40147000.0,"EarningsPerShareBasic_1_Q3_USD":0.77,"EarningsPerShareBasic_3_Q3_USD":-0.5,"WeightedAverageNumberOfDilutedSharesOutstanding_3_Q3_shares":106974000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q3_shares":117552000.0,"GainsLossesOnExtinguishmentOfDebt_1_Q3_USD":-255000.0,"GainsLossesOnExtinguishmentOfDebt_3_Q3_USD":-255000.0,"OtherNonoperatingIncomeExpense_3_Q3_USD":1892000.0,"OtherNonoperatingIncomeExpense_1_Q3_USD":301000.0,"AccountsReceivableNetCurrent_0_Q3_USD":1383000.0,"IncreaseDecreaseInDeferredRevenue_3_Q3_USD":0.0,"CommonStockValue_0_Q3_USD":117000.0,"Revenues_3_Q3_USD":23796000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q3_USD":52251000.0,"Revenues_1_Q3_USD":6634000.0,"DebtInstrumentInterestRateStatedPercentage_0_Q3_pure":0.09,"DepreciationDepletionAndAmortization_3_Q3_USD":2590000.0,"CashAndCashEquivalentsPeriodIncreaseDecrease_3_Q3_USD":16139000.0,"NetCashProvidedByUsedInFinancingActivities_3_Q3_USD":-211786000.0,"RealizedInvestmentGainsLosses_3_Q3_USD":0.0,"UnamortizedDebtIssuanceExpense_0_Q3_USD":130000.0,"StockIssuedDuringPeriodSharesNewIssues_1_Q3_shares":9333000.0,"OtherAssetsCurrent_0_Q3_USD":9109000.0,"IncreaseDecreaseInInventories_3_Q3_USD":-345000.0,"ComprehensiveIncomeNetOfTax_3_Q3_USD":-53128000.0,"ComprehensiveIncomeNetOfTax_1_Q3_USD":82326000.0,"AmortizationOfIntangibleAssets_3_Q3_USD":1200000.0,"AmortizationOfIntangibleAssets_1_Q3_USD":300000.0,"IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_3_Q3_USD":14281000.0,"ResearchAndDevelopmentExpense_3_Q3_USD":152629000.0,"UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted_3_Q3_USD":-53079000.0,"ImpairmentOfRealEstate_1_Q3_USD":0.0,"DebtInstrumentFairValue_0_Q3_USD":15400000.0,"DilutiveSecuritiesEffectOnBasicEarningsPerShareOther_3_Q3_USD":0.0,"DilutiveSecuritiesEffectOnBasicEarningsPerShareOther_1_Q3_USD":1258000.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q3_USD":63795000.0,"Goodwill_0_Q3_USD":44543000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_3_Q3_USD":-53079000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q3_USD":82603000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q3_USD":1904000.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-108730000.0,"WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":106974000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":107309000.0,"IncrementalCommonSharesAttributableToConversionOfDebtSecurities_3_Q3_shares":0.0,"IncrementalCommonSharesAttributableToConversionOfDebtSecurities_1_Q3_shares":10192000.0,"DeferredFederalIncomeTaxExpenseBenefit_1_Q3_USD":0.0,"LiabilitiesCurrent_0_Q3_USD":78922000.0,"InterestExpense_3_Q3_USD":14374000.0,"InterestExpense_1_Q3_USD":4118000.0,"CashAndCashEquivalentsFairValueDisclosure_0_Q3_USD":52251000.0,"SeveranceCosts1_3_Q3_USD":5500000.0,"LongTermDebtNoncurrent_0_Q3_USD":11629000.0,"OtherAccruedLiabilitiesCurrent_0_Q3_USD":1704000.0,"IntangibleAssetsNetExcludingGoodwill_0_Q3_USD":0.0,"IncreaseDecreaseInOtherOperatingAssets_3_Q3_USD":-314000.0,"AdditionalPaidInCapital_0_Q3_USD":1486853000.0,"StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_0_Q3_USD":87639000.0,"PreferredStockSharesIssued_0_Q3_shares":0.0,"PropertyPlantAndEquipmentNet_0_Q3_USD":11106000.0,"NetIncomeLoss_1_Q3_USD":82603000.0,"AccountsPayableCurrent_0_Q3_USD":11734000.0,"UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted_1_Q3_USD":83861000.0,"DeferredFederalIncomeTaxExpenseBenefit_3_Q3_USD":0.0,"EarningsPerShareDiluted_1_Q3_USD":0.71,"ImpairmentOfRealEstate_3_Q3_USD":1600000.0,"CommonStockParOrStatedValuePerShare_0_Q3_USD":0.001,"ProceedsFromSaleOfProductiveAssets_0_Q3_USD":160385000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_3_Q3_USD":6008000.0,"CommonStockSharesAuthorized_0_Q3_shares":225000000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_3_Q3_USD":33000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q3_USD":0.0,"OperatingIncomeLoss_3_Q3_USD":-40342000.0,"OperatingIncomeLoss_1_Q3_USD":86675000.0,"PaymentsForRepurchaseOfCommonStock_3_Q3_USD":1026000.0,"InventoryNet_0_Q3_USD":0.0,"PreferredStockValue_0_Q3_USD":0.0,"DeferredIncomeTaxExpenseBenefit_3_Q3_USD":0.0,"InvestmentsFairValueDisclosure_0_Q3_USD":111446000.0,"LiabilitiesAndStockholdersEquity_0_Q3_USD":178928000.0,"OperatingLeaseLiabilityCurrent_0_Q3_USD":553000.0,"OperatingExpenses_3_Q3_USD":196956000.0,"OperatingExpenses_1_Q3_USD":52777000.0,"OtherLiabilitiesNoncurrent_0_Q3_USD":738000.0,"StockholdersEquity_0_Q3_USD":87639000.0,"PaymentsToAcquirePropertyPlantAndEquipment_3_Q3_USD":33000.0,"IntangibleAssetsNetIncludingGoodwill_0_Q3_USD":18500000.0,"AmortizationOfFinancingCostsAndDiscounts_3_Q3_USD":995000.0,"RetainedEarningsAccumulatedDeficit_0_Q3_USD":-1394523000.0,"IncreaseDecreaseInAccountsReceivable_3_Q3_USD":-52201000.0,"AssetImpairmentCharges_3_Q3_USD":0.0,"AssetImpairmentCharges_1_Q3_USD":0.0,"EarningsPerShareDiluted_3_Q3_USD":-0.5,"PreferredStockSharesAuthorized_0_Q3_shares":5000000.0,"ShortTermInvestments_0_Q3_USD":59195000.0,"Ticker":"LXRX","CIK":"1062822","name":"LEXICON PHARMACEUTICALS, INC.","OfficialName":"Lexicon Pharmaceuticals Inc. Common Stock","form":"10-Q","period":"20200930","fy":"2020.0","fp":"Q3","qtrs":"3","uom":"USD","footnote":"nan","Market Cap":"332097683.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Biological Products (No Diagnostic Substances)","Market":"NASDAQ","SP500":"nan","filed":"20201030"}]